Thermo Fisher Scientific Unveils $6 Million Expansion at Viral Vector Manufacturing Facility November 22, 2019November 22, 2019 by / Share This.....LinkedinTwitterFacebookGoogleEmailInvestment doubles the site’s process development capabilities and establishes commercial testing Related News: PerkinElmer Agrees to Acquire Viral Vector Gene…Expanded Gene Therapy Portfolio Supports More…Neogen Ceremonially Breaks Ground on $70 Million…Thermo Fisher Scientific Opens cGMP Plasmid DNA…Thermo Fisher Scientific Selects Mebane, N.C. as…Thermo Fisher Scientific Awarded $192.5 Million U.S.…Share this:Click to share on Twitter (Opens in new window)Click to share on Facebook (Opens in new window)
